<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>novel pyrazole derivatives as antibiotics &#8211; Science</title>
	<atom:link href="https://scienmag.com/tag/novel-pyrazole-derivatives-as-antibiotics/feed/" rel="self" type="application/rss+xml" />
	<link>https://scienmag.com</link>
	<description></description>
	<lastBuildDate>Sat, 12 Sep 2026 17:44:25 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1</generator>

<image>
	<url>https://scienmag.com/wp-content/uploads/2024/07/cropped-scienmag_ico-32x32.jpg</url>
	<title>novel pyrazole derivatives as antibiotics &#8211; Science</title>
	<link>https://scienmag.com</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">73899611</site>	<item>
		<title>Phosphorus-Powered Pyrazoles Show Potent Antimicrobial Activity Against E. coli</title>
		<link>https://scienmag.com/phosphorus-powered-pyrazoles-show-potent-antimicrobial-activity-against-e-coli/</link>
		
		<dc:creator><![CDATA[Bethany Barker]]></dc:creator>
		<pubDate>Sat, 12 Sep 2026 17:44:25 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Antibiotic resistance]]></category>
		<category><![CDATA[antimicrobial activity]]></category>
		<category><![CDATA[Antimicrobial activity of phosphorus-containing pyrazoles]]></category>
		<category><![CDATA[development of new antibacterial]]></category>
		<category><![CDATA[E. coli inhibition]]></category>
		<category><![CDATA[electronic and steric effects of organophosphorus substituents]]></category>
		<category><![CDATA[Escherichia coli]]></category>
		<category><![CDATA[Gram-negative bacteria]]></category>
		<category><![CDATA[heterocyclic synthesis]]></category>
		<category><![CDATA[medicinal chemistry]]></category>
		<category><![CDATA[medicinal chemistry of pyrazoles with phosphorus]]></category>
		<category><![CDATA[NMR spectroscopy]]></category>
		<category><![CDATA[novel pyrazole derivatives as antibiotics]]></category>
		<category><![CDATA[one-pot synthesis of antibacterial compounds]]></category>
		<category><![CDATA[organophosphorus]]></category>
		<category><![CDATA[phosphonohydrazine]]></category>
		<category><![CDATA[pyrazole]]></category>
		<category><![CDATA[role of organophosphorus groups in drug design]]></category>
		<category><![CDATA[structural influence on antibacterial efficacy]]></category>
		<category><![CDATA[structure-activity relationship]]></category>
		<category><![CDATA[synthesis of N-phosphorylated 5-aminopyrazoles]]></category>
		<category><![CDATA[tackling antimicrobial resistance with pyrazole scaffolds]]></category>
		<category><![CDATA[thiophosphonate]]></category>
		<guid isPermaLink="false">https://scienmag.com/?p=197063</guid>

					<description><![CDATA[Chemists have synthesized a series of N-phosphorylated 5-aminopyrazoles that show promising antibacterial activity, with one thiophosphorylated derivative approaching the potency of ampicillin against Escherichia coli.]]></description>
										<content:encoded><![CDATA[<p>Chemists in Tunisia have unveiled a new family of phosphorus-containing pyrazole molecules that show striking antibacterial activity, particularly against the Gram-negative pathogen Escherichia coli. The study, published in the journal Discover Chemistry, describes an efficient one-pot synthetic route to N-phosphorylated 5-aminopyrazoles and provides the first systematic look at how subtle structural changes in these compounds influence their ability to kill bacteria. With antimicrobial resistance rising worldwide, the work offers a fresh chemical scaffold that could underpin the next generation of infection-fighting drugs.</p>
<p>Pyrazoles are five-membered rings containing two adjacent nitrogen atoms, and they have been a mainstay of medicinal chemistry since their discovery by Ludwig Knorr in 1883. Their ring positions can be readily functionalized, allowing chemists to tune properties such as lipophilicity, metabolic stability, and target binding. Pyrazole derivatives have been investigated as anti-inflammatory, antifungal, antidiabetic, and anticancer agents, and they also serve as ligands in catalysis and materials science. Yet despite this rich history, relatively few studies have combined the pyrazole framework with organophosphorus groups, a class of substituents known for their unique electronic and steric properties and their proven value in pharmaceuticals and agrochemicals.</p>
<p>The research team, Dhiab Jabli and Mohamed Lotfi Efrit of the Laboratory of Selective Organic and Heterocyclic Synthesis at El Manar University in Tunis, addressed this gap by exploiting phosphonohydrazines as versatile building blocks. These reagents, which pair a nucleophilic hydrazine unit with a phosphoryl or thiophosphoryl group, react efficiently with activated alpha,beta-unsaturated nitriles under mild conditions. In the reported synthesis, two phosphonohydrazine precursors, a diethyl phosphonate and an O,O-diphenyl phosphonothioate, were reacted with a series of five activated nitrile substrates in ethanol with a catalytic amount of acetic acid under reflux for nine hours. The result was a library of ten N-phosphorylated 5-aminopyrazoles isolated in good to excellent yields ranging from 64 to 83 percent.</p>
<p>The proposed mechanism follows a well-established logic for electron-deficient olefins. The terminal amino group of the phosphonohydrazine first performs a Michael-type nucleophilic attack on the beta-carbon of the unsaturated nitrile. The remaining nitrogen then cyclizes intramolecularly onto the cyano group, closing the pyrazole ring, and a final tautomerization delivers the thermodynamically favored 5-amino-4-cyanopyrazole product. The authors are careful to note that this pathway is a plausible proposal grounded in literature precedents rather than definitive mechanistic proof, since no intermediates were isolated or directly observed. The absence of splitting in the nuclear magnetic resonance spectra, however, indicates that each reaction produces a single isomer, validating the selectivity of the route.</p>
<p>Structural confirmation relied on a comprehensive battery of analytical techniques. Fourier-transform infrared spectroscopy revealed the characteristic nitrile stretch near 2240 wavenumbers, amino absorptions between 3435 and 3355 wavenumbers, and phosphoryl bands consistent with P=O or P=S functionality. Proton and carbon-13 NMR spectra in DMSO-d6 mapped every substituent, with carbon-phosphorus coupling constants of roughly 23 to 25 hertz providing direct evidence of bonding between the ring framework and the phosphoryl substituent. Most diagnostic were the phosphorus-31 NMR chemical shifts: the phosphonate derivatives resonated between -1.34 and -2.63 parts per million, while the thiophosphonate analogues appeared far downfield between 49.78 and 61.63 parts per million, a deshielding attributed to the anisotropic environment of the pyrazole ring and to intramolecular hydrogen bonding between the phosphoryl group and the primary amine. Liquid chromatography tandem mass spectrometry and elemental analysis completed the structural picture, with characteristic fragment ions at mass-to-charge ratios of 137 and 248 corresponding to the phosphonate and thiophosphonate cores respectively.</p>
<p>To probe biological activity, the team selected four representative compounds, 3a, 3e, 4a, and 4e, chosen to capture the principal structural variations in the series: phosphonate versus phosphonothioate functionality and different substituents at the C-3 position of the ring. Using standard disc diffusion assays on Mueller-Hinton agar with bacterial suspensions standardized to 0.5 McFarland, the compounds were tested at 100, 150, and 200 micrograms per milliliter against four clinically relevant strains: Salmonella typhimurium, Enterococcus faecium, Staphylococcus aureus, and Escherichia coli. Ampicillin served as the reference antibiotic and DMSO-treated discs as negative controls, with all experiments performed in triplicate and analyzed by one-way ANOVA followed by Tukey&#8217;s post hoc test.</p>
<p>The results were striking. Activity was consistently stronger against Gram-negative bacteria than Gram-positive ones, with a sensitivity order of S. typhimurium, S. aureus, E. faecium, and finally E. coli, which showed the largest inhibition zones, reaching up to 22 millimeters at the highest concentration. This Gram-negative potency is noteworthy because the outer membrane of these bacteria typically blocks many conventional antibiotics. The fact that the N-phosphorylated aminopyrazoles retained measurable activity suggests they may bypass or disrupt this defensive barrier. While the compounds did not surpass ampicillin in overall potency, their activity profile points to a mechanism of action potentially complementary to beta-lactam drugs.</p>
<p>Structure-activity analysis revealed clear trends. Phosphonothioate derivatives generally outperformed their phosphonate analogues, a difference the authors attribute to the higher polarizability of sulfur, which may strengthen hydrophobic interactions with bacterial membranes and facilitate cellular penetration. The single most active compound was 4e, which combines the thiophosphoryl group with a methylthio substituent at C-3, a pairing that increases lipophilicity and reshapes the electronic distribution of the scaffold. Its minimum bactericidal concentration to minimum inhibitory concentration ratio fell below 2, indicating genuinely bactericidal rather than merely bacteriostatic action, and its MIC and MBC values approached those of ampicillin. By contrast, compound 3e showed reduced activity, likely due to steric hindrance and diminished aqueous solubility.</p>
<p>The molecular explanation for this potency is multifactorial. The nitrogen-rich pyrazole ring serves as a hydrogen-bond donor and acceptor network capable of engaging bacterial enzymes, nucleic acids, and membrane phospholipids, potentially disrupting DNA replication, cell-wall biosynthesis, and metabolic function. The amino and imine functionalities enhance electrostatic complementarity with polar enzyme cavities, while the phosphoryl group can coordinate essential metal cofactors such as zinc and magnesium ions, inhibiting metalloenzymes involved in oxidative stress regulation. Additionally, the conjugated pi-system of the heteroaromatic scaffold may stack with nucleobases in microbial DNA, interfering with replication and transcription. In compound 4e, these electronic effects, hydrogen-bonding capacity, and balanced lipophilicity appear to act synergistically, maximizing membrane permeability, enzyme affinity, and intracellular stability.</p>
<p>The authors emphasize that this biological evaluation is a preliminary screening, but it establishes an initial structure-activity relationship that can guide rational design. Future work will extend testing to the remaining derivatives, employ molecular docking and computational studies against bacterial targets to clarify the mechanism of action, and evaluate activity against multidrug-resistant strains. For a field urgently seeking alternatives to failing antibiotics, phosphorus-functionalized pyrazoles have now earned a place on the shortlist of promising scaffolds, and the Tunisian team&#8217;s efficient synthetic route provides the practical chemistry needed to explore that potential at scale.</p>
<p><strong>Subject of Research:</strong> Synthesis of N-phosphorylated 5-aminopyrazole derivatives and evaluation of their antimicrobial activity</p>
<p><strong>Article Title:</strong> Phosphonohydrazine mediated synthesis of N phosphorylated 5 aminopyrazoles with structural characterization and antimicrobial activity</p>
<p><strong>Article References:</strong> Phosphonohydrazine mediated synthesis of N phosphorylated 5 aminopyrazoles with structural characterization and antimicrobial activity. (n.d.). <a href="https://doi.org/10.1007/s44371-026-00949-2" rel="noopener noreferrer">https://doi.org/10.1007/s44371-026-00949-2</a></p>
<p><strong>Image Credits:</strong> AI Generated</p>
<p><strong>DOI:</strong> <a href="https://doi.org/10.1007/s44371-026-00949-2" rel="noopener noreferrer">10.1007/s44371-026-00949-2</a></p>
<p><strong>Keywords:</strong> pyrazole, organophosphorus, antimicrobial activity, Escherichia coli, phosphonohydrazine, heterocyclic synthesis, antibiotic resistance, NMR spectroscopy, structure-activity relationship, medicinal chemistry, Gram-negative bacteria, thiophosphonate</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">197063</post-id>	</item>
	</channel>
</rss>
